Life Science

An optically active isomer of TBP-OH, a compound produced from the metabolism of the organophosphorus solvent, TBP.

An optically active isomer of TBP-OH, a compound produced from the metabolism of the organophosphorus solvent, TBP.

An optically active isomer of TBP-OH, a compound produced from the metabolism of the organophosphorus solvent, TBP.

An optically active isomer of TBP-OH, a compound produced from the metabolism of the organophosphorus solvent, TBP.

A potent inhibitor of serotonin and norepinephrine reuptake (Kis = 4.6 and 15.6 nM, respectively, for rat synaptosomes) less effectively inhibits dopamine reuptake (Ki = 369 nM) effective in cells, tissues, and in vivo.

A potent inhibitor of serotonin and norepinephrine reuptake (Kis = 4.6 and 15.6 nM, respectively, for rat synaptosomes) less effectively inhibits dopamine reuptake (Ki = 369 nM) effective in cells, tissues, and in vivo.

A potent inhibitor of serotonin and norepinephrine reuptake (Kis = 4.6 and 15.6 nM, respectively, for rat synaptosomes) less effectively inhibits dopamine reuptake (Ki = 369 nM) effective in cells, tissues, and in vivo.

A potent inhibitor of serotonin and norepinephrine reuptake (Kis = 4.6 and 15.6 nM, respectively, for rat synaptosomes) less effectively inhibits dopamine reuptake (Ki = 369 nM) effective in cells, tissues, and in vivo.

The naturally occurring enantiomer of equol that demonstrates ER agonist activity similar to that of genistein (EC50 = 85 and 65 nM for human ER&alpha and ER&beta, respectively) preferentially binds ER&beta (Ki = 0.73 nM) with lower affinity for

The naturally occurring enantiomer of equol that demonstrates ER agonist activity similar to that of genistein (EC50 = 85 and 65 nM for human ER&alpha and ER&beta, respectively) preferentially binds ER&beta (Ki = 0.73 nM) with lower affinity for

The naturally occurring enantiomer of equol that demonstrates ER agonist activity similar to that of genistein (EC50 = 85 and 65 nM for human ER&alpha and ER&beta, respectively) preferentially binds ER&beta (Ki = 0.73 nM) with lower affinity for

The naturally occurring enantiomer of equol that demonstrates ER agonist activity similar to that of genistein (EC50 = 85 and 65 nM for human ER&alpha and ER&beta, respectively) preferentially binds ER&beta (Ki = 0.73 nM) with lower affinity for